Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense Paclitaxel and Cisplatin in Operable NSCLC
NCT00291850Phase 2Terminated
- Sponsor
- Central European Cooperative Oncology Group
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of paclitaxel, cisplatin in non-small cell lung cancer (NSCLC), sponsored by Central European Cooperative Oncology Group. Started Jun 2005; status: terminated.
02
Drugs
paclitaxelcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00291850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291850.